Promising Pharmacological Directions in the World of Lysophosphatidic Acid Signaling

Lysophosphatidic acid (LPA) is a signaling lipid that binds to six known lysophosphatidic acid receptors (LPARs), named LPA1-LPA6. These receptors initiate signaling cascades relevant to development, maintenance, and healing processes throughout the body. The diversity and specificity of LPA signaling, especially in relation to cancer and autoimmune disorders, makes LPA receptor modulation an attractive target for drug development. Several LPAR-specific analogues and small molecules have been synthesized and are efficacious in attenuating pathology in disease models. To date, at least three compounds have passed phase I and phase II clinical trials for idiopathic pulmonary fibrosis and systemic sclerosis. This review focuses on the promising therapeutic directions emerging in LPA signaling toward ameliorating several diseases, including cancer, fibrosis, arthritis, hydrocephalus, and traumatic injury.

• Publication year

  2015

• Venue

  Biomolecules & Therapeutics

• Publication date

  2015-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.4062/biomolther.2014.109PMID 25593637PMCID 4286743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase

  2014cited by this paper
• Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice

  2014cited by this paper
• LPA receptor signaling: pharmacology, physiology, and pathophysiology

  2014influential reference
• Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes

  2014cited by this paper
• Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.

  2014cited by this paper
• Diagnostic and prognostic significance of lysophosphatidic acid in malignant pleural effusions.

  2014cited by this paper
• Transforming growth factor β—at the centre of systemic sclerosis

  2014cited by this paper
• Autotaxin–Lysophosphatidic Acid Signaling Axis Mediates Tumorigenesis and Development of Acquired Resistance to Sunitinib in Renal Cell Carcinoma

  2013cited by this paper
• Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis

  2013cited by this paper
• Autotaxin inhibition: development and application of computational tools to identify site-selective lead compounds.

  2013cited by this paper
• Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation.

  2013cited by this paper
• Hits of a High-Throughput Screen Identify the Hydrophobic Pocket of Autotaxin/Lysophospholipase D As an Inhibitory Surface

  2013cited by this paper
• A Metabolically-Stabilized Phosphonate Analog of Lysophosphatidic Acid Attenuates Collagen-Induced Arthritis

  2013cited by this paper
• Autotaxin Inhibition with PF-8380 Enhances the Radiosensitivity of Human and Murine Glioblastoma Cell Lines

  2013cited by this paper
• Lysophosphatidic acid: chemical signature of neuropathic pain.

  2013influential reference
• Lysophosphatidic Acid Stimulates Activation of Focal Adhesion Kinase and Paxillin and Promotes Cell Motility, via LPA1–3, in Human Pancreatic Cancer

  2013cited by this paper
• Lysophospholipid Receptors: Signaling and Biochemistry

  2013cited by this paper
• Suppression of metastasis of intravenously-inoculated B16/F10 melanoma cells by the novel ginseng-derived ingredient, gintonin: involvement of autotaxin inhibition.

  2013cited by this paper
• Screening and X-ray crystal structure-based optimization of autotaxin (ENPP2) inhibitors, using a newly developed fluorescence probe.

  2013cited by this paper
• PF‐8380 and Closely Related Analogs: Synthesis and Structure–Activity Relationship towards Autotaxin Inhibition and Glioma Cell Viability

  2013cited by this paper
• Lysophosphatidic acid increases proximal tubule cell secretion of profibrotic cytokines PDGF-B and CTGF through LPA2- and Gαq-mediated Rho and αvβ6 integrin-dependent activation of TGF-β.

  2012cited by this paper
• Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.

  2012cited by this paper
• Autotaxin-Lysophosphatidic Acid Axis Is a Novel Molecular Target for Lowering Intraocular Pressure

  2012cited by this paper
• Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.

  2012cited by this paper
• The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion

  2012cited by this paper
• Blockage of lysophosphatidic acid signaling improves spinal cord injury outcomes.

  2012cited by this paper
• Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells.

  2012cited by this paper
• Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo

  2012cited by this paper
• Lysophosphatidic Acid Increases Proximal Tubule Cell Secretion of Profibrotic Cytokines PDGF-B and CTGF through LPA2- and G (cid:1) q-Mediated Rho and (cid:1) v (cid:2) 6 Integrin-Dependent Activation of TGF- (cid:2)

  2012cited by this paper
• Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis.

  2012influential reference
• Lysophosphatidic Acid Signaling May Initiate Fetal Hydrocephalus

  2011influential reference
• Lysophosphatidic acid (LPA)—a perspective marker in ovarian cancer

  2011cited by this paper
• LPA Is a Chemorepellent for B16 Melanoma Cells: Action through the cAMP-Elevating LPA5 Receptor

  2011cited by this paper
• Autotaxin and LPA Receptors Represent Potential Molecular Targets for the Radiosensitization of Murine Glioma through Effects on Tumor Vasculature

  2011influential reference
• LPA5 Is Abundantly Expressed by Human Mast Cells and Important for Lysophosphatidic Acid Induced MIP-1β Release

  2011cited by this paper
• Pharmacokinetic and Pharmacodynamic Characterization of an Oral Lysophosphatidic Acid Type 1 Receptor-Selective Antagonist

  2011cited by this paper
• Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.

  2011cited by this paper
• Benzyl and Naphthalene Methylphosphonic Acid Inhibitors of Autotaxin with Anti‐invasive and Anti‐metastatic Activity

  2011cited by this paper
• LPA1‐induced migration requires nonmuscle myosin II light chain phosphorylation in breast cancer cells

  2011cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature

  2010cited by this paper
• Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis

  2010cited by this paper
• A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model

  2010cited by this paper
• Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three‐dimensional lung cancer xenograft model

  2010influential reference
• Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors

  2010cited by this paper
• LPA receptors: subtypes and biological actions.

  2010cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

  2010cited by this paper
• A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation

  2010cited by this paper
• Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo.

  2009cited by this paper
• Identification and Characterization of a Novel Lysophosphatidic Acid Receptor, p2y5/LPA6*

  2009cited by this paper
• Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents.

  2008cited by this paper
• Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion

  2008cited by this paper
• Genome-wide linkage analysis of an autosomal recessive hypotrichosis identi fi es a novel P 2 RY 5 mutation

  2008cited by this paper
• G protein–coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth

  2008cited by this paper
• Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs

  2008cited by this paper
• Genome-wide linkage analysis of an autosomal recessive hypotrichosis identifies a novel P2RY5 mutation.

  2008cited by this paper
• Role of LPA4/p2y9/GPR23 in negative regulation of cell motility.

  2008cited by this paper
• Novel mutations in G protein-coupled receptor gene (P2RY5) in families with autosomal recessive hypotrichosis (LAH3)

  2008cited by this paper
• Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during Development

  2006cited by this paper
• Lysophosphatidic Acid Binds to and Activates GPR92, a G Protein-Coupled Receptor Highly Expressed in Gastrointestinal Lymphocytes

  2006cited by this paper
• Autotaxin Stabilizes Blood Vessels and Is Required for Embryonic Vasculature by Producing Lysophosphatidic Acid*

  2006cited by this paper
• Lysophospholipids as mediators of immunity.

  2006cited by this paper
• GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5*

  2006cited by this paper
• Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma

  2006cited by this paper
• GPR 92 as a New G 12 / 13-and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP , LPA 5 *

  2006cited by this paper
• LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing

  2005cited by this paper
• Lysophosphatidic Acid and Autotaxin Stimulate Cell Motility of Neoplastic and Non-neoplastic Cells through LPA1*

  2004influential reference
• Lysophospholipid receptors: signaling and biology.

  2004cited by this paper
• Protein Kinase Cδ Mediates Lysophosphatidic Acid-induced NF-κB Activation and Interleukin-8 Secretion in Human Bronchial Epithelial Cells*

  2004cited by this paper
• Protein kinase Cdelta mediates lysophosphatidic acid-induced NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells.

  2004cited by this paper
• Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation

  2004cited by this paper
• Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury.

  2003cited by this paper
• Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family*

  2003cited by this paper
• Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer.

  2002cited by this paper
• The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors*

  2002cited by this paper
• Lysophosphatidic acid as a novel cell survival/apoptotic factor.

  2002cited by this paper
• A Novel Phosphatidic Acid-selective Phospholipase A1That Produces Lysophosphatidic Acid*

  2002cited by this paper
• Characterization of lpa2 (Edg4) and lpa1/lpa2 (Edg2/Edg4) Lysophosphatidic Acid Receptor Knockout Mice: Signaling Deficits without Obvious Phenotypic Abnormality Attributable to lpa2

  2002cited by this paper
• Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase*

  2002cited by this paper
• Multiple Mechanisms Linked to Platelet Activation Result in Lysophosphatidic Acid and Sphingosine 1-Phosphate Generation in Blood*

  2002cited by this paper
• Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production

  2002cited by this paper
• Lysophospholipid receptors.

  2001cited by this paper
• Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists

  2001cited by this paper
• Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing.

  2000cited by this paper
• Role of the Pi3k Regulatory Subunit in the Control of Actin Organization and Cell Migration

  2000cited by this paper
• G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors

  1999cited by this paper
• Developmental expression analysis of murine autotaxin (ATX).

  1999cited by this paper
• Molecular Cloning and Characterization of a Novel Human G-protein-coupled Receptor, EDG7, for Lysophosphatidic Acid*

  1999cited by this paper
• Lysophosphatidic acid stimulates protein kinase C isoforms α, β, ε, and ζ in a pertussis toxin sensitive pathway in vascular smooth muscle cells

  1999cited by this paper
• Lysophosphatidic acid stimulates protein kinase C isoforms alpha, beta, epsilon, and zeta in a pertussis toxin sensitive pathway in vascular smooth muscle cells.

  1999cited by this paper
• Signal-regulated activation of serum response factor is mediated by changes in actin dynamics.

  1999cited by this paper
• Characterization of a Novel Subtype of Human G Protein-coupled Receptor for Lysophosphatidic Acid*

  1998cited by this paper
• Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth.

  1998cited by this paper
• Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex

  1996cited by this paper
• Activation of protein kinase C by lysophosphatidic acid: dependence on composition of phospholipid vesicles.

  1996cited by this paper
• Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells.

  1995cited by this paper
• The bioactive phospholipid lysophosphatidic acid is released from activated platelets.

  1993cited by this paper
• Growth factor-like action of lysophosphatidic acid: mitogenic signalling mediated by G proteins.

  1990cited by this paper
• Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux.

  1979cited by this paper
• Identification of vasopressor phospholipid in crude soybean lecithin

  1978cited by this paper

• Uncovering a Glaucoma-Linked Lysophosphatidic Acid–MAPK/AP-1 Fibrosis Axis in Human Trabecular Meshwork Cells and Its Modulation by Diospyros kaki Leaf Extract

  2026cites this paper
• Anticancer drug-treated fibroblasts modulate colon cancer cell behavior through lysophosphatidic acid (LPA) receptor-mediated signaling.

  2026cites this paper
• Lysophosphatidic Acid (LPA) Receptor Signaling Promotes the Adaptation of Malignant Cellular Functions in Highly Migratory Osteosarcoma Cells Under Hypoxic and Low-Glucose Conditions

  2025cites this paper
• Unraveling the Role of Autotaxin and Lysophosphatidic Acid in Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Potential

  2025cites this paper
• Lysophosphatidic acid (LPA) receptor signaling enhances malignant potential in highly migratory lung cancer cells under hypoxic conditions.

  2025cites this paper
• Distinct roles of lysophosphatidic acid (LPA) receptor signaling in regulating gastric cancer cell functions under chemical versus physiological hypoxia.

  2025cites this paper
• LPAR6 Inhibits the Progression of Hepatocellular Carcinoma (HCC) by Suppressing the Nuclear Translocation of YAP/TAZ

  2025cites this paper
• Affinity of Nintedanib Towards New Candidate Target for Idiopathic Pulmonary Fibrosis

  2024cites this paper
• The effect of lysophosphatidic acid on myometrial contractility and the mRNA transcription of its receptors in the myometrium at different stages of endometrosis in mares

  2024cites this paper
• Cellular responses to low nutrient conditions via activation of lysophosphatidic acid (LPA) receptor signaling in gastric cancer cells.

  2024cites this paper
• The role of LPA receptor signaling in modulating cellular responses of colon cancer cells co-cultured with lymphoid endothelial cells under hypoxic stress.

  2024cites this paper
• Impact of cellular ATP levels on cell viability in response to fluorouracil through lysophosphatidic acid (LPA) receptor-4 (LPA4) and LPA6 in colon cancer cells.

  2024cites this paper
• Autotaxin–Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications

  2024cites this paper
• Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cancer cell biology

  2024cites this paper
• Involvement of lysophosphatidic acid (LPA) receptor-mediated signaling in breast cancer cell functions by long-term tamoxifen treatment under hypoxic and estrogen-deprived conditions.

  2024cites this paper
• Raman spectroscopy‐based molecularly imprinted polymer sensor for sensitive detection of lysophosphatidic acid in serum

  2024cites this paper
• LPA-induced Expression of CCN2 in Muscular Fibro/adipogenic Progenitors (FAPs): Unraveling Cellular Communication Networks.

  2024cites this paper
• Plasma Metabolite Profiling Identifies Nondiabetic Chronic Pancreatitis Patients With Metabolic Alterations Progressing to Prediabetes Before HbA1c

  2024cites this paper
• Lysophosphatidic acid (LPA) receptor-mediated signaling regulates hypoxia-induced biological functions of lymphatic endothelial cells.

  2024cites this paper
• Lysophosphatidic Acid Receptor 1 Plays a Pathogenic Role in Permanent Brain Ischemic Stroke by Modulating Neuroinflammatory Responses

  2024influential citation
• Regulation of cellular responses to X-ray irradiation through the activation of lysophosphatidic acid (LPA) receptor-3 (LPA3) and LPA2 in osteosarcoma cells.

  2024cites this paper
• High expression of autotaxin is associated with poor recurrence‐free survival in cholangiocarcinoma

  2024cites this paper
• Lysophosphatidic acid (LPA) receptor-mediated signaling and cellular responses to anticancer drugs and radiation of cancer cells.

  2024cites this paper
• Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cellular functions modulated by endothelial cells in pancreatic cancer cells under hypoxic conditions.

  2024cites this paper
• Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein–Ligand Interactions and High Selectivity

  2024cites this paper
• LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration

  2023cites this paper
• Induction of lysophosphatidic acid (LPA) receptor-mediated signaling regulates cell motility and survival to anticancer drugs in cancer cells treated with hydrogen peroxide.

  2023cites this paper
• Roles of lysophosphatidic acid (LPA) receptor-2 (LPA2) in the regulation of cellular responses induced by X-ray irradiation and hydrogen peroxide in pancreatic cancer cells

  2023cites this paper
• Effects of LPA receptor-mediated signaling on the modulation of cellular functions of pancreatic cancer cells cultured in fibroblast supernatants under hypoxic conditions

  2023cites this paper
• LPA receptor-mediated signaling regulates cell motility and survival to anticancer drug of pancreatic cancer cells under glucose-deprived and hypoxic conditions.

  2023cites this paper
• Differential targeting of lysophosphatidic acid LPA1, LPA2, and LPA3 receptor signalling by tricyclic and tetracyclic antidepressants.

  2023cites this paper
• In Vitro Animal Model for Estimating the Time since Death with Attention to Early Postmortem Stage

  2022cites this paper
• Alteration of Cellular Energy Metabolism through LPAR2-Axin2 Axis in Gastric Cancer

  2022cites this paper
• Lysophosphatidic acid signaling via LPA6: A negative modulator of developmental oligodendrocyte maturation

  2022cites this paper
• Effects of lysophosphatidic acid (LPA) signaling via LPA receptors on cellular functions associated with ATP reduction in osteosarcoma cells treated with ethidium bromide

  2022cites this paper
• Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells

  2021cites this paper
• Interfering with lysophosphatidic acid receptor edg2/lpa1 signalling slows down disease progression in SOD1‐G93A transgenic mice

  2021cites this paper
• LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β

  2021cites this paper
• Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies

  2021cites this paper
• Autotaxin-LPA Axis in Obesity and Obesity-related Diseases

  2021cites this paper
• Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications

  2021cites this paper
• Changes in Plasma Phospholipid Metabolism Are Associated with Clinical Manifestations of Systemic Sclerosis

  2021cites this paper
• Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?

  2021cites this paper
• Singlet‐Oxygen‐Induced Phospholipase A2 Inhibition: A Major Role for Interfacial Tryptophan Dioxidation

  2021cites this paper
• Lysophosphatidic Acid: Promoter of Cancer Progression and of Tumor Microenvironment Development. A Promising Target for Anticancer Therapies?

  2021cites this paper
• Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development.

  2021cites this paper
• The lysophosphatidic acid axis in fibrosis: Implications for glaucoma

  2021cites this paper
• Effects of lysophosphatidic acid (LPA) receptor-2 (LPA2) and LPA3 on the regulation of chemoresistance to anticancer drug in lung cancer cells.

  2020cites this paper
• LPA5-mediated signaling induced by endothelial cells and anticancer drug regulates cellular functions of osteosarcoma cells.

  2020cites this paper
• Inhibition of store-operated calcium channels by N-arachidonoyl glycine (NAGly): no evidence for the involvement of lipid-sensing G protein coupled receptors

  2020cites this paper
• Lysophosphatidic Acid and Hematopoiesis: From Microenvironmental Effects to Intracellular Signaling

  2020cites this paper
• Circ0004390 promotes cell proliferation through sponging miR-198 in ovarian cancer.

  2020cites this paper
• Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway

  2020influential citation
• Lysophosphatidic acid receptor-2 (LPA2)-mediated signaling enhances chemoresistance in melanoma cells treated with anticancer drugs

  2020cites this paper
• Unlabeled lysophosphatidic acid receptor binding in free solution as determined by a compensated interferometric reader

  2020cites this paper
• Different effects of lysophosphatidic acid receptor-2 (LPA2) and LPA5 on the regulation of chemoresistance in colon cancer cells

  2020cites this paper
• Lysophosphatidic Acid Receptor 5 Contributes to Imiquimod-Induced Psoriasis-Like Lesions through NLRP3 Inflammasome Activation in Macrophages

  2020cites this paper
• Cooperation of G12/13 and Gi proteins via lysophosphatidic acid receptor-2 (LPA2) signaling enhances cancer cell survival to cisplatin.

  2020cites this paper
• Inhibition of Lysophosphatidic Acid Receptor 1 Attenuates Neuroinflammation via PGE2/EP2/NOX2 Signalling and Improves the Outcome of Intracerebral Haemorrhage in Mice.

  2020cites this paper
• BMS-986020, a Specific LPA1 Antagonist, Provides Neuroprotection against Ischemic Stroke in Mice

  2020cites this paper
• NLRP3 Inflammasome Activation Is Involved in LPA1-Mediated Brain Injury after Transient Focal Cerebral Ischemia

  2020cites this paper
• Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA2) and LPA3 in osteosarcoma cells.

  2020cites this paper
• Inhibition of lysophosphatidic acid receptor 1–3 deteriorates experimental autoimmune encephalomyelitis by inducing oxidative stress

  2020cites this paper
• Lipid metabolism and Calcium signaling in epithelial ovarian cancer.

  2019cites this paper
• G Protein-Coupled Receptor Systems and Their Role in Cellular Senescence

  2019cites this paper
• Rapid establishment of highly migratory cells from cancer cells for investigating cellular functions

  2019cites this paper
• Lysophosphatidic acid receptor 1 (LPA1) plays critical roles in microglial activation and brain damage after transient focal cerebral ischemia

  2019cites this paper
• Recent advances in rational diagnosis and treatment of normal pressure hydrocephalus: A critical appraisal on novel diagnostic, therapy monitoring and treatment modalities.

  2019cites this paper
• Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders.

  2019cites this paper
• LPA1/3 overactivation induces neonatal posthemorrhagic hydrocephalus through ependymal loss and ciliary dysfunction

  2019cites this paper
• Autotaxin-Lysophosphatidic Acid Signaling Contributes to Obesity-Induced Insulin Resistance in Muscle and Impairs Mitochondrial Metabolism

  2019cites this paper
• Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA5 in melanoma cells treated with anticancer drugs.

  2019cites this paper
• Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease.

  2019cites this paper
• Benzoxaboroles—Novel Autotaxin Inhibitors

  2019cites this paper
• Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials

  2019cites this paper
• microRNA‐501‐5p promotes cell proliferation and migration in gastric cancer by downregulating LPAR1

  2019cites this paper
• Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment

  2019cites this paper
• A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration.

  2019cites this paper
• Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance

  2018influential citation
• Involvement of LPA receptor-5 in the enhancement of cell motile activity by phorbol ester and anticancer drug treatments in melanoma A375 cells.

  2018cites this paper
• Effects of LPA1 and LPA6 on the regulation of colony formation activity in colon cancer cells treated with anticancer drugs

  2018cites this paper
• Involvement of LPA signaling via LPA receptor‐2 in the promotion of malignant properties in osteosarcoma cells

  2018cites this paper
• Identification of compounds acting as negative allosteric modulators of the LPA1 receptor

  2018cites this paper
• Systemic blockade of LPA1/3 lysophosphatidic acid receptors by ki16425 modulates the effects of ethanol on the brain and behavior

  2018cites this paper
• Extracellular Vesicles as Conveyors of Membrane-Derived Bioactive Lipids in Immune System

  2018cites this paper
• Tissue-resident mesenchymal stromal cells: Implications for tissue-specific antifibrotic therapies

  2018influential citation
• Fibrosis and Immune Dysregulation in Systemic Sclerosis

  2018cites this paper
• Lysophosphatidic acid triggers cathepsin B-mediated invasiveness of human endometriotic cells.

  2018cites this paper
• Therapeutic targets and early stage clinical trials for pulmonary fibrosis

  2018cites this paper
• Mechanisms of Lysophosphatidic Acid-Mediated Lymphangiogenesis in Prostate Cancer

  2018cites this paper
• Promotion of cell-invasive activity through the induction of LPA receptor-1 in pancreatic cancer cells

  2018cites this paper
• Lysophosphatidic acid receptor-2 (LPA2) and LPA5 regulate cellular functions during tumor progression in fibrosarcoma HT1080 cells.

  2018cites this paper
• Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism[S]

  2018cites this paper
• Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment

  2018cites this paper
• Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fib

  2017cites this paper
• Lysophosphatidic Acid Receptor 4 Activation Augments Drug Delivery in Tumors by Tightening Endothelial Cell-Cell Contact.

  2017cites this paper
• Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors.

  2017cites this paper
• Myofibroblast-Mediated Contraction.

  2017cites this paper
• Comprehensive Analysis of Non-Synonymous Natural Variants of G Protein-Coupled Receptors

  2017cites this paper
• Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice

  2017cites this paper